by Danielle Bonadies | Jun 13, 2017 | Genetic Journal
On June 13, 2013, in the case of the Association for Molecular Pathology v. Myriad Genetics, Inc., the Supreme Court of the United States ruled that human genes cannot be patented in the U.S. because DNA is a “product of nature.” The Court decided that...
by Danielle Bonadies | Apr 28, 2015 | Genetic Journal
Color Genomics just announced that for a mere $249 they are offering genetic testing for a panel of genes that will include BRCA1, BRCA2 and 17 other genes associated with cancer risk. Considering that the lead competitor in this space offers their cancer gene panel...
